New AI-based applications and major collaborations are set to drive further efficiencies in Singapore’s public health system.
During its inaugural AI conference, Synapxe, Singapore’s national health tech agency, revealed AI-centred partnerships with big tech, new proof-of-concept (POC) AI solutions, and initiatives to help upskill the public health workforce in the use of AI.
Big tech collabs
At the AI Accelerate 2025 Conference, Synapxe illustrated plans to promote digital health adoption through strategic collaborations with four leading technology partners:
OpenAI: They will explore multi-agentic frameworks to streamline everyday healthcare tasks, such as appointment booking and general queries, via privacy-by-design prototypes.
AIDX TECH: Their partnership will focus on identifying and mitigating AI risks in healthcare, leveraging AIDX’s platform for AI model testing to ensure safety, reliability, and compliance with global frameworks such as ISO 42001 and the European Union AI Act.
Databricks: This partnership will promote AI adoption, co-develop predictive care use cases, integrate Databricks’ AI capabilities, and include a three-year programme to train and certify public healthcare professionals in data and AI. It is also focused on strengthening the national cloud-based analytics platform, HEALIX.
Google Cloud: Synapxe will tap into Google Cloud’s data and AI services to improve HEALIX and Synapxe’s secure genAI platform, Tandem. This collaboration also features a comprehensive initiative to train and certify over 300 healthcare technology professionals in AI.
AI in the pipeline
Synapxe demonstrated several new features of its medical imaging AI platform, AimSG, early-stage POC tools, and supplementary AI services to existing national healthcare data repositories on HealthHub.
AimSG is gaining two new AI use cases: a chest X-ray AI model for tuberculosis (TB) screening will be tested at the National Healthcare Group’s (NHG) National TB Screening Centre, while a bone trauma interpretation AI model will be trialled at the emergency departments at Woodlands Health.
The POC tool, ASPIRE (AI-enabled Short Performance Physical Battery Evaluation), developed with NHG, is designed to help clinicians effectively screen for sarcopenia in more accessible settings such as polyclinics.
Another POC tool, Synseh, does tongue pattern analysis related to traditional Chinese medicine using computer vision and AI to provide personalised wellness recommendations for early intervention.
It was also announced that an AI-enabled conversational assistant will be integrated into the HealthHub website later this year. HealthHub AI was built to provide multilingual, personalised health information via text and voice. A beta version was launched in April.
GenAI to upskill health workforce
The Synapxe conference has also showcased different genAI-based prototypes developed through its two competitions.
At one competition, AWS LLM League 2025, participants trained and fine-tuned LLM solutions in a gamified environment over five weeks. The top four teams showcased their models for a live audience voting at the conference.
Launched in April 2024, the GenAIus Challenge connected over 160 public healthcare professionals with technology partners, including AWS and Microsoft, to apply genAI solutions for approximately 70 real-world use cases. There were eight early version products presented at the conference. One of the featured working prototypes from the GenAIus Challenge, “CareScribe,” demonstrated how speech-to-text technology combined with genAI can automate the transcription of verbal nurse and medical notes during shift handovers, aiming to reduce manual documentation time while improving information accuracy.
Selected prototypes will later undergo rigorous testing and iteration before a phased deployment in clinical settings.
This focused effort on AI innovations aligns with Singapore’s broader national strategy. As part of the National AI Strategy 2.0, the government recently announced a $150 million investment to accelerate genAI integration within public healthcare and medical research institutions. This initiative aims to enhance patient care, reduce administrative burdens, improve operational efficiencies, and empower healthcare professionals by building talent and fostering responsible use of the technology.
“AI holds immense promise for transforming healthcare through innovation. By harnessing its capabilities, we are developing solutions that enhance predictive and personalised care and improve health outcomes for everyone.
At Synapxe, we build a bridge to an AI-ready healthcare, anchored on empowering people, fostering a vibrant ecosystem, establishing infrastructure, and enabling responsible innovation. Together with our partners, we transform data into vision, ensuring that the human experience remains at the heart of healthcare.”
Siew Ying, CEO, Synapxe
